A History of Repeated Alcohol Intoxication Promotes Cognitive Impairment and Gene Expression Signatures of Disease Progression in the 3xTg Mouse Model of Alzheimer’s Disease

Visual Abstract The impact of alcohol abuse on Alzheimer’s disease (AD) is poorly understood. Here, we show that the onset of neurocognitive impairment in a mouse model of AD is hastened by repeated alcohol intoxication through exposure to alcohol vapor, and we provide a comprehensive gene expression dataset of the prefrontal cortex by the single-nucleus RNA sequencing of 113,242 cells. We observed a broad dysregulation of gene expression that involves neuronal excitability, neurodegeneration, and inflammation, including interferon genes. Several genes previously associated with AD in humans by genome-wide association studies were differentially regulated in specific neuronal populations. The gene expression signatures of AD mice with a history of alcohol intoxication showed greater similarity to the signatures of older AD mice with advanced disease and cognitive impairment than did the gene expression signatures of AD mice not exposed to alcohol, suggesting that alcohol promotes transcriptional changes consistent with AD progression. Our gene expression dataset at the single-cell level provides a unique resource for investigations of the molecular bases of the detrimental role of excessive alcohol intake in AD.

[1]  Xuezhong Li,et al.  The clinical correlation between Alzheimer's disease and epilepsy , 2022, Frontiers in Neurology.

[2]  Fei Li,et al.  A Diagnostic Model for Alzheimer’s Disease Based on Blood Levels of Autophagy-Related Genes , 2022, Frontiers in Aging Neuroscience.

[3]  F. Giorgi,et al.  The R Language: An Engine for Bioinformatics and Data Science , 2022, Life.

[4]  Viktoriya D. Nikolova,et al.  Adolescent Binge Alcohol Enhances Early Alzheimer’s Disease Pathology in Adulthood Through Proinflammatory Neuroimmune Activation , 2022, Frontiers in Pharmacology.

[5]  Z. Wang,et al.  ATG16L2 inhibits NLRP3 inflammasome activation through promoting ATG5‐12‐16L1 complex assembly and autophagy , 2022, European journal of immunology.

[6]  S. Edland,et al.  Midlife alcohol consumption and later life cognitive impairment: Light drinking is not protective and APOE genotype does not change this relationship , 2022, PloS one.

[7]  K. Lunetta,et al.  Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[8]  S. Jakobs,et al.  Defining the interactome of the human mitochondrial ribosome identifies SMIM4 and TMEM223 as respiratory chain assembly factors , 2021, eLife.

[9]  Evan Z. Macosko,et al.  A transcriptomic and epigenomic cell atlas of the mouse primary motor cortex , 2021, Nature.

[10]  G. Petrosillo,et al.  Exploring the Ability of LARS2 Carboxy-Terminal Domain in Rescuing the MELAS Phenotype , 2021, Life.

[11]  Conor D. Cox,et al.  Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer’s disease , 2021, Nature Communications.

[12]  A. Mortazavi,et al.  Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease , 2021, bioRxiv.

[13]  L. Mewton,et al.  Alcohol use and dementia: new research directions. , 2020, Current opinion in psychiatry.

[14]  Araxi O. Urrutia,et al.  Transcriptional, Behavioral and Biochemical Profiling in the 3xTg-AD Mouse Model Reveals a Specific Signature of Amyloid Deposition and Functional Decline in Alzheimer’s Disease , 2020, Frontiers in Neuroscience.

[15]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[16]  P. Greengard,et al.  Innate immunity protein IFITM3 modulates γ-secretase in Alzheimer disease , 2020, Nature.

[17]  P. Greengard,et al.  The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease , 2020, Nature.

[18]  W. Wong Economic burden of Alzheimer disease and managed care considerations. , 2020, The American journal of managed care.

[19]  A. Zarbock,et al.  ArhGAP15, a RacGAP, Acts as a Temporal Signaling Regulator of Mac-1 Affinity in Sterile Inflammation , 2020, The Journal of Immunology.

[20]  2020 Alzheimer's disease facts and figures , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[21]  Daniele Mercatelli,et al.  corto: a lightweight R package for Gene Network Inference and Master Regulator Analysis , 2020, bioRxiv.

[22]  D. Y. Lee,et al.  Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study , 2020, PLoS medicine.

[23]  Nicholas E. Propson,et al.  Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. , 2020, The Journal of clinical investigation.

[24]  S. Baserga,et al.  Ribosomopathies: Old Concepts, New Controversies. , 2019, Trends in genetics : TIG.

[25]  Gary D. Bader,et al.  Single-cell transcriptomic profiling of the aging mouse brain , 2019, Nature Neuroscience.

[26]  J. Williamson,et al.  Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment , 2019, JAMA network open.

[27]  A. Agoglia,et al.  Alcohol Drinking Exacerbates Neural and Behavioral Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease , 2019, bioRxiv.

[28]  S. Newhouse,et al.  Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains , 2019, Brain, Behavior, and Immunity.

[29]  S. Quake,et al.  Brain endothelial cells are exquisite sensors of age-related circulatory cues , 2019, bioRxiv.

[30]  P. Lewczuk,et al.  Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease , 2019, Alzheimer's Research & Therapy.

[31]  R. Firestein,et al.  Molecular and in vivo Functions of the CDK8 and CDK19 Kinase Modules , 2019, Front. Cell Dev. Biol..

[32]  J. Rehm,et al.  Alcohol use and dementia: a systematic scoping review , 2019, Alzheimer's Research & Therapy.

[33]  M. Sortino,et al.  Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease? , 2018, CNS neuroscience & therapeutics.

[34]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[35]  A. Klegeris,et al.  Emerging roles of microglial cathepsins in neurodegenerative disease , 2018, Brain Research Bulletin.

[36]  Carole Dufouil,et al.  Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. , 2018, The Lancet. Public health.

[37]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[38]  Jae-Rin Lee,et al.  Regulation of inflammatory gene expression in macrophages by epithelial-stromal interaction 1 (Epsti1). , 2017, Biochemical and biophysical research communications.

[39]  R. Weinberg,et al.  Cadherin-10 Maintains Excitatory/Inhibitory Ratio through Interactions with Synaptic Proteins , 2017, The Journal of Neuroscience.

[40]  Shiyong Huang,et al.  Developmental Disruption of GABAAR-Meditated Inhibition in Cntnap2 KO Mice , 2017, eNeuro.

[41]  P. Gregersen,et al.  Increased Cathepsin S in Prdm1−/− dendritic cells alters TFH repertoire and contributes to lupus , 2017, Nature Immunology.

[42]  S. Newton,et al.  Cognitive dysfunction in major depression and Alzheimer’s disease is associated with hippocampal–prefrontal cortex dysconnectivity , 2017, Neuropsychiatric disease and treatment.

[43]  Zhengdong D. Zhang,et al.  Cyclin C regulates adipogenesis by stimulating transcriptional activity of CCAAT/enhancer-binding protein α , 2017, The Journal of Biological Chemistry.

[44]  F. Crews,et al.  Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7 , 2017, Journal of Neuroinflammation.

[45]  L. Tan,et al.  Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies , 2017, European Journal of Epidemiology.

[46]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[47]  S. Shultz,et al.  Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype , 2016, Acta neuropathologica communications.

[48]  D. Kang Visual perceptual learning for the treatment of visual field defect , 2015 .

[49]  V. Vorobyov,et al.  The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy , 2015, Neural regeneration research.

[50]  Takuya Kumazawa,et al.  Perturbation of ribosome biogenesis drives cells into senescence through 5S RNP-mediated p53 activation. , 2015, Cell reports.

[51]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[52]  A W Toga,et al.  FASTKD2 is associated with memory and hippocampal structure in older adults , 2014, Molecular Psychiatry.

[53]  Rona S. Gertner,et al.  Single cell RNA Seq reveals dynamic paracrine control of cellular variation , 2014, Nature.

[54]  A. Palmeri,et al.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines. , 2014, Biochemical pharmacology.

[55]  P. Mulholland,et al.  Chronic Alcohol Disrupts Dopamine Receptor Activity and the Cognitive Function of the Medial Prefrontal Cortex , 2014, The Journal of Neuroscience.

[56]  F. LaFerla,et al.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions. , 2012, Current pharmaceutical design.

[57]  Mark Ellisman,et al.  Cadherin-9 Regulates Synapse-Specific Differentiation in the Developing Hippocampus , 2011, Neuron.

[58]  Rajita Sinha,et al.  Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study. , 2011, The American journal of psychiatry.

[59]  P. S. St George-Hyslop,et al.  The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease , 2010, International journal of geriatric psychiatry.

[60]  E. Birney,et al.  Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.

[61]  A. Owen,et al.  AGEMAP: A Gene Expression Database for Aging in Mice , 2007, PLoS genetics.

[62]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[63]  P. Sanna,et al.  Increased expression of protein kinase A inhibitor α (PKI-α) and decreased PKA-regulated genes in chronic intermittent alcohol exposure , 2007, Brain Research.

[64]  C. Cotman,et al.  Metallothionein-I and -III expression in animal models of Alzheimer disease , 2006, Neuroscience.

[65]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[66]  Kevin G Becker,et al.  Transcriptional Profiling of Aging in Human Muscle Reveals a Common Aging Signature , 2006, PLoS genetics.

[67]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[68]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[70]  K. Iwamoto,et al.  Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia , 2005, Biological Psychiatry.

[71]  H. Becker,et al.  Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. , 2004, Alcoholism, clinical and experimental research.

[72]  P. Gorelick,et al.  Risk Factors for Vascular Dementia and Alzheimer Disease , 2004, Stroke.

[73]  K. Coyle,et al.  Cognitive impairments in sober alcoholics: performance on selective and divided attention tasks. , 2004, Drug and alcohol dependence.

[74]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[75]  L. Kuller,et al.  Prospective study of alcohol consumption and risk of dementia in older adults. , 2003, JAMA.

[76]  H. Stöhr,et al.  Cloning and characterization of WDR17, a novel WD repeat-containing gene on chromosome 4q34. , 2002, Biochimica et biophysica acta.

[77]  W. Shan,et al.  Neural (N‐) cadherin, a synaptic adhesion molecule, is induced in hippocampal mossy fiber axonal sprouts by seizure , 2002, Journal of neuroscience research.

[78]  A. Pfefferbaum,et al.  Pattern of motor and cognitive deficits in detoxified alcoholic men. , 2000, Alcoholism, clinical and experimental research.

[79]  R. Hale,et al.  Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal "kindling". , 1993, Alcoholism, clinical and experimental research.

[80]  R. Morris Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[81]  Ventura County,et al.  Alzheimer’s Association , 2020, The Grants Register 2021.

[82]  J. Delgado-García,et al.  Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[83]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[84]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[85]  P. Sanna,et al.  Increased expression of protein kinase A inhibitor alpha (PKI-alpha) and decreased PKA-regulated genes in chronic intermittent alcohol exposure. , 2007, Brain Research.

[86]  W. Gaebel,et al.  Out-patient behaviour therapy in alcoholism: impact of personality disorders and cognitive impairments. , 2001 .